US Stock MarketDetailed Quotes

TAK Takeda Pharmaceutical

Watchlist
  • 13.190
  • +0.110+0.84%
Close May 1 16:00 ET
  • 13.300
  • +0.110+0.83%
Post 17:12 ET
41.74BMarket Cap37.26P/E (TTM)

About Takeda Pharmaceutical Company

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Company Profile

SymbolTAK
Company NameTakeda Pharmaceutical
Listing DateDec 24, 2018
Founded1781
CEOMr. Christophe Weber
MarketNYSE
Employees49095
Securities TypeDR
ADS Ratio2.0 : 1.0
Fiscal Year Ends03-31
Address4-1-1 Dosho-machi,Chuo-Ku
CityOsaka
ProvinceOsaka
CountryJapan
Zip Code540-8645
Phone81-6-6204-2111
Websitehttp://www.takeda.co.jp

Company Executives

  • Name
  • Position
  • Salary
  • Christophe Weber
  • Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.A., Inc.
  • 1.72B
  • Lauren Duprey
  • Chief Human Resources Officer
  • --
  • Costa Saroukos
  • Director and Chief Financial Officer
  • 2.49B
  • Takako Ohyabu
  • Chief Global Corporate Affairs and Sustainability Officer
  • --
  • Gabriele Ricci
  • Chief Data and Technology Officer
  • --
  • Mwana Lugogo
  • Chief Ethics and Compliance Officer
  • --
  • Koki Sato
  • Corporate Strategy Officer
  • --
  • Dr. Thomas Wozniewski, PhD
  • Global Manufacturing and Supply Officer
  • --
  • Marcello Agosti
  • Global Business Development Officer
  • --
  • Ramona Sequeira
  • President, Global Portfolio Division
  • --
  • Julie Kim
  • President, U.S. Business Unit and U.S. Country Head
  • --
  • Milano Furuta
  • President, Japan Pharma Business Unit
  • --
  • Giles Platford
  • President, Plasma-Derived Therapies Business Unit
  • --
  • Andrew S. Plump, M.D.
  • Director and President, Research and Development
  • 972.00M
  • Teresa Bitetti
  • President, Global Oncology Business Unit
  • --
  • Masami Iijima
  • Chairman of the Board
  • 43.00M
  • Olivier Bohuon
  • Independent Director
  • 38.00M
  • Jean-Luc Butel
  • Independent Director
  • 38.00M
  • Dr. Steven Gillis, Pd.D
  • Independent Director
  • 38.00M
  • Michel Orsinger
  • Independent Director
  • 39.00M
  • Kimberly A. Reed
  • Independent Director
  • 34.00M
  • Yoshiaki Fujimori
  • Independent Director
  • 41.00M
  • Miki Tsusaka
  • Independent Director
  • --
  • Koji Hatsukawa
  • Independent Director
  • 43.00M
  • Emiko Higashi
  • Independent Director
  • 43.00M
  • Ian T. Clark
  • Independent Director
  • 38.00M
  • Dr. John M. Maraganore,PhD
  • Independent Director
  • 32.00M
  • Yoshihiro Nakagawa
  • Global General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg